Skip to content
Menu

H World Group Posts Upbeat Q3 Earnings, Joins CG Oncology, TELUS And Other Big Stocks Moving Higher On Monday

Avi Kapoor 1 hour ago

MarketsTrading IdeasMoversIntraday UpdateNews

U.S. stocks fell, but H World Group surged 9.3% on strong Q3 results and raised guidance; several other stocks posted notable gains.

U.S. stocks were lower, with the Nasdaq Composite falling around 500 points on Monday.

Shares of H World Group Limited (NASDAQ:HTHT) rose sharply after the company reported better-than-expected third-quarter financial results and raised its FY26 sales guidance.

H World Group reported quarterly earnings of 93 cents per share which beat the analyst consensus estimate of 78 cents per share. The company reported quarterly sales of $1.156 billion which beat the analyst consensus estimate of $1.140 billion.

H World Group shares jumped 9.3% to $55.08 on Monday.

Here are some other big stocks recording gains in today’s session.

  • mF International Limited (NASDAQ:MFI) shares jumped 17.1% to $8.89.
  • CG Oncology, Inc. (NASDAQ:CGON) rose 12% to $83.35 after the company announced PIVOT-006 achieved its primary endpoint.
  • TELUS Corporation (NYSE:TU) gained 11.9% to $9.55 after Québecor submitted an unsolicited, non-binding, and conditional proposal to acquire the company.
  • Bgin Blockchain Limited (NASDAQ:BGIN) gained 10.7% to $4.2900.
  • Katapult Holdings, Inc. (NASDAQ:KPLT) gained 9.7% to $9.69.
  • Gyre Therapeutics, Inc. (NASDAQ:GYRE) gained 8.9% to $4.6950.
  • Tyson Foods, Inc. (NYSE:TSN) climbed 8.5% to $63.82 as the company posted better-than-expected earnings for the fourth quarter.
  • Fennec Pharmaceuticals Inc. (NASDAQ:FENC) climbed 8.4% to $12.60 after B. Riley Securities raised its price target on the stock from $18 to $19.
  • Molina Healthcare, Inc. (NYSE:MOH) gained 8.3% to $226.79.
  • AEVEX Corp. (NYSE:AVEX) rose 8.1% to $13.52.
  • Zevra Therapeutics, Inc. (NASDAQ:ZVRA) gained 6.2% to $9.65. Guggenheim analyst Eddie Hickman maintained Zevra Therapeutics with a Buy and lowered the price target from $23 to $18.

Photo via Shutterstock

Read at benzinga.com